Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Workplace Health Saf ; 71(7): 329-336, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37002663

ABSTRACT

BACKGROUND: Healthcare organizations need to attract and retain qualified nurses, and break areas may influence nurse engagement with breaks, but this has not been studied in situ. The goal of this study was to understand nurse perception of breaks and ways building design and culture impact the frequency, duration, and location of nurse breaks. METHODS: This was Part 1 of a two-part study. Mixed-method approaches included on-site behavior mapping, focus groups, online survey, and break room usage rates analysis. FINDINGS: In this study, nurses did not take restorative breaks but focused on quick "bio" breaks in rooms nearest the central nurse station. When nurses left care floors, they preferred the cafeteria and outdoor eating spaces. CONCLUSION: Nurses' proclivity to minimize restorative breaks remains a major organizational concern. Future studies should investigate leadership activities impacting nurses' perception of shifts and break-taking behavior. APPLICATION TO PRACTICE: By optimizing the break setting and changing the cultural perspective of breaks, occupational health services and healthcare management can support nurses' engagement in restorative activities.


Subject(s)
Motivation , Personal Satisfaction , Humans , Job Satisfaction
2.
Front Immunol ; 12: 763877, 2021.
Article in English | MEDLINE | ID: mdl-35069536

ABSTRACT

Malignant melanoma is an aggressive form of cancer, which can be treated with anti-CTLA-4 and anti-PD-1 checkpoint inhibitor antibodies but while anti-CTLA-4 antibodies have clear benefits for some patients with melanoma, productive responses are difficult to predict and often associated with serious immune related adverse events. Antibodies specific to CTLA-4 bind two major isoforms of CTLA-4 in humans, the receptor isoform and a second naturally secretable, soluble isoform - sCTLA-4. The primary aim here was to examine the effect of selectively blocking the function of sCTLA-4 on in vitro immune responses from volunteer healthy or melanoma patient PBMC samples. Addition of recombinant sCTLA-4 to healthy PBMC samples demonstrated sCTLA-4 to have immunosuppressive capacity comparable to recombinant CTLA4-Ig, partially reversible upon antibody blockade. Further, we identified a mechanistic relationship where melanoma patient TGFß2 serum levels correlated with sCTLA-4 levels and provided the basis for a novel protocol to enhance sCTLA-4 production and secretion by T cells with TGFß2. Finally, a comparison of selective antibody blockade of sCTLA-4 demonstrated that both healthy and melanoma patient effector cytokine responses can be significantly increased. Overall, the data support the notion that sCTLA-4 is a contributory factor in cancer immune evasion.


Subject(s)
Antibodies, Neoplasm/immunology , CTLA-4 Antigen/immunology , Immune Checkpoint Inhibitors , Melanoma , Neoplasm Proteins/immunology , Transforming Growth Factor beta2/immunology , Adult , Aged , Aged, 80 and over , Animals , Cell Line, Tumor , Female , Humans , Male , Melanoma/immunology , Melanoma/therapy , Mice , Middle Aged
3.
J Dermatolog Treat ; 24(1): 64-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-21797808

ABSTRACT

OBJECTIVES: This study evaluated self-reported patient adherence to different types of treatment in psoriasis and factors that affect adherence. PATIENTS AND METHODS: Patients attending a Dermatology Department for treatments of psoriasis completed a questionnaire about adherence to each of their therapies, Self-assessed Psoriasis Area and Severity Index (SAPASI) and Dermatology Life Quality Index (DLQI). RESULTS: Hundred and six patients participated, 98 on topical treatments, 43 on oral systemic therapies, 39 on phototherapy and 29 were on biologic therapies. The overall rate of self-reported treatment adherence was 85.8%. There was a significant relationship between the types of treatment (topical, oral systemic, phototherapy and biologic therapy) and the number of combinations of treatments and adherence. Adherence ranked significantly better on biologic therapies 100%, followed by oral therapy 96%, phototherapy 93% and then topical therapy 75%. Being too busy, being fed up and cigarette smoking were associated with reduced adherence. About 56.8% of patients reported that messiness of treatment prevented them from adhering. Patients with mild psoriasis and those with DLQI of 5 or less adhered less to topical therapy. CONCLUSIONS: There is a significant relationship between the types of treatment (topical, oral systemic, phototherapy and biologic therapy) and the number of combinations of treatments and adherence.


Subject(s)
Biological Therapy , Dermatologic Agents/therapeutic use , Patient Compliance/statistics & numerical data , Phototherapy , Psoriasis/therapy , Administration, Topical , Adult , Aged , Combined Modality Therapy , Female , Health Status , Humans , Male , Middle Aged , Quality of Life , Self Disclosure , Sickness Impact Profile , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...